Sangamo Therapeutics
SGMO
SGMO
210 hedge funds and large institutions have $767M invested in Sangamo Therapeutics in 2020 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+5
Holders Change %
+2.44%
% of All Funds
4.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
32
Increased
55
Reduced
69
Closed
25
Calls
$14.1M
Puts
$11M
Net Calls
+$3.14M
Net Calls Change
-$1.82M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
$12.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$12.7M |
| 3 |
Nuveen Asset Management
Chicago,
Illinois
|
$12.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
$5.87M |
| 5 |
State Street
Boston,
Massachusetts
|
$66.4M |
Top Sellers
| 1 |
BlackRock
New York
|
$93.5M |
| 2 |
CC
Casdin Capital
New York
|
$10.2M |
| 3 |
Two Sigma Investments
New York
|
$16.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$76.8M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
$3.28M |
